Integra Lifesciences Holdings (IART) Interest Expenses (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Interest Expenses of $358.6 million for Q2 2026, little changed sequentially from $359.9 million in Q1 2026, and down 19.56% YoY from $445.8 million in Q2 2025.
Integra Lifesciences Holdings (IART) Interest Expenses (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Interest Expenses for 18 years, with the latest figure at $358.6 million in Q2 2026.
- Quarterly Interest Expenses fell 19.56% year-over-year to $358.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $358.6 million (down 19.56% YoY) and the FY2025 annual result came in at $447.7 million, up 533.85% from the prior year.
- Interest Expenses held at $358.6 million in Q2 2026 per IART's latest filing, from $359.9 million in the prior quarter.
- Over five years, Interest Expenses peaked at $511.8 million in Q3 2024 and troughed at $13.8 million in Q4 2023.
- A 5-year average of $361.3 million and a median of $446.7 million in 2025 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2023 and 2024: Interest Expenses plunged 62.62% in 2023, then soared 38.06% in 2024.
- Over 5 years, Interest Expenses stood at $36.8 million in 2022, then slumped by 62.62% to $13.8 million in 2023, then jumped by 38.06% to $19.0 million in 2024, then grew by 24.7% to $23.7 million in 2025, then surged by 1414.81% to $358.6 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $358.6 million, $359.9 million, and $23.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 141.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 176.00 Mn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 96.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 114.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -110.42 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Integra Lifesciences Holdings | 1.30 Bn | 1.02 Bn | 219.74 Mn | 22.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 358.60 Mn |
| Jun 30, 2026 | 358.60 Mn |
| Mar 31, 2026 | 359.90 Mn |
| Mar 31, 2026 | 359.90 Mn |
| Dec 31, 2025 | 23.67 Mn |
| Dec 31, 2025 | 23.67 Mn |
| Sep 30, 2025 | 447.60 Mn |
| Sep 30, 2025 | 447.60 Mn |
| Jun 30, 2025 | 445.80 Mn |
| Jun 30, 2025 | 445.80 Mn |
| Mar 31, 2025 | 439.20 Mn |
| Mar 31, 2025 | 439.20 Mn |
| Dec 31, 2024 | 18.98 Mn |
| Dec 31, 2024 | 18.98 Mn |
| Sep 30, 2024 | 511.80 Mn |
| Sep 30, 2024 | 511.80 Mn |
| Jun 30, 2024 | 506.80 Mn |
| Jun 30, 2024 | 506.80 Mn |
| Mar 31, 2024 | 403.50 Mn |
| Mar 31, 2024 | 403.50 Mn |